Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/18/2009 | CA2709305A1 Compositions and methods for early pregnancy diagnosis |
06/18/2009 | CA2709213A1 Polymeric sorbent sheets as ion reservoirs for electroblotting |
06/18/2009 | CA2709207A1 Use of kir genes for predicting response to therapy |
06/18/2009 | CA2708719A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles |
06/18/2009 | CA2708492A1 Modulators of neuronal regeneration |
06/18/2009 | CA2708256A1 Cell assay kit and method |
06/18/2009 | CA2707902A1 Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator |
06/18/2009 | CA2707886A1 Biomarkers for predicting the sensitivity of cells to immunomodulatory compounds during treatment of non-hodgkin's lymphoma |
06/18/2009 | CA2707729A1 Biomarkers for monitoring the treatment by quinazolinone compounds |
06/18/2009 | CA2707315A1 Rapid charging and power management of a battery-powered fluid analyte meter |
06/18/2009 | CA2707300A1 Rapid-read gated amperometry |
06/18/2009 | CA2706115A1 Seprase as a marker for cancer |
06/18/2009 | CA2705837A1 Recombinant bacteriophage for detection of nosocomial infection |
06/18/2009 | CA2705783A1 Resonance energy transfer based detection of nosocomial infection |
06/18/2009 | CA2705716A1 Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies |
06/18/2009 | CA2703794A1 Methods of diagnosing cancer |
06/18/2009 | CA2701970A1 Marker panel for colorectal cancer |
06/17/2009 | EP2071481A2 Method system, apparatus and device for discovering and preparing chemical compounds for medical and other uses |
06/17/2009 | EP2071339A2 System for providing animal test information and method of providing animal test information |
06/17/2009 | EP2071338A2 Human diabetes-mediating proteins |
06/17/2009 | EP2071337A1 Seprase as a marker for cancer |
06/17/2009 | EP2071336A1 Serum proteomic for finding diagnostic markers and for monitoring therapeutical intervention in treatment of hepatocellular carcinoma |
06/17/2009 | EP2071335A2 Detection of auto-antibodies from patients suffering from rheumatoid arthritis |
06/17/2009 | EP2071334A1 Compositions and methods of detecting TIABS |
06/17/2009 | EP2071333A2 Method of selectively assaying adiponectin multimers |
06/17/2009 | EP2071332A1 Method for monitoring persons with IBD using total endogeneous lactoferrin as a marker |
06/17/2009 | EP2071331A2 Biosensors with porous chromatographic membranes |
06/17/2009 | EP2071329A2 Method for predecting a parameter of a bitumen and relative prevision system |
06/17/2009 | EP2071326A1 Measuring device and sensor ejecting method |
06/17/2009 | EP2071321A2 Surface plasmon resonance biosensor |
06/17/2009 | EP2071313A1 Method for deparaffinization of paraffin-embedded specimen and method for analysis of paraffin-embedded specimen |
06/17/2009 | EP2071042A1 DNA Diagnostics based on mass spectrometry |
06/17/2009 | EP2071040A2 Diagnostics and therapeutics for vascular disease |
06/17/2009 | EP2071037A1 Vessel for blood sampling |
06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
06/17/2009 | EP2070947A1 Therapeutic and diagnostic anti-Hsp70 antibodies |
06/17/2009 | EP2070939A1 Modulators of pharmacological agents |
06/17/2009 | EP2070697A2 Fountain solution processing including hardness change |
06/17/2009 | EP2070548A1 Diagnosis and treatment of cancer using anti-ereg antibody |
06/17/2009 | EP2070546A1 Preventives/remedies for cancer |
06/17/2009 | EP2069798A2 Elisa for vegf |
06/17/2009 | EP2069797A2 Methods for analysing protein samples based on the identification of c-terminal peptides |
06/17/2009 | EP2069796A2 Methods and systems for quantifying isobaric labels and peptides |
06/17/2009 | EP2069795A1 Synergistic treatment of cells that express epha2 and erbb2 |
06/17/2009 | EP2069794A1 Grp78 as a predictor of responsiveness to therapeutic agents |
06/17/2009 | EP2069793A1 Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer |
06/17/2009 | EP2069792A1 Method and kit for detecting if an individual is susceptible to progress to an active mycobacterial disease |
06/17/2009 | EP2069791A1 Cellular receptor for antiproliferative factor |
06/17/2009 | EP2069790A2 Binding surfaces for affinity assays |
06/17/2009 | EP2069789A2 Intermediates and methods for forming passivated surfaces on oxide layers and articles produced thereby |
06/17/2009 | EP2069788A2 Multifunctional encoded particles for high-throughput analysis |
06/17/2009 | EP2069787A1 Rotatable test element |
06/17/2009 | EP2069786A1 Method of detection |
06/17/2009 | EP2069785A1 Immobilisation of fluorescent proteins |
06/17/2009 | EP2069784A1 Il-33 in inflammatory disease |
06/17/2009 | EP2069783A1 Biosensor, manufacturing method thereof, and biosensing apparatus including the same |
06/17/2009 | EP2069782A1 Method for determining the quantity and quality of hybridomas as well as the use of hybridomas of suitable quality |
06/17/2009 | EP2069781A1 Prognosis and therapy of liver failure |
06/17/2009 | EP2069780A1 Ultrasound method |
06/17/2009 | EP2069779A2 Multi-detector gas identification system |
06/17/2009 | EP2069778A2 Methods and compositions for identifying biomarkers |
06/17/2009 | EP2069777A1 Device for a textile machine for measuring the length-specific mass and/or the moisture of a strand-shaped, continuous fiber batch, and textile machine |
06/17/2009 | EP2069776A2 Method and apparatus for analyzing solutions |
06/17/2009 | EP2069769A2 Method of detecting interactions on a microarray using nuclear magnetic resonance |
06/17/2009 | EP2069768A2 Compositions and methods for diagnosis and treatment of type 2 diabetes |
06/17/2009 | EP2069765A1 Method and device for monitoring the condition of a medium |
06/17/2009 | EP2069764A1 Method and device for monitoring the condition of a medium |
06/17/2009 | EP2069748A2 Integrated sample cell and filter and system using same |
06/17/2009 | EP2069747A2 Sidestream gas sampling system with closed sample circuit |
06/17/2009 | EP2069722A1 Method for detachably connecting a sensor for fluid analysis to a body containing said fluid, and corresponding apparatus |
06/17/2009 | EP2069561A1 Device for a textile machine for measuring the length-specific mass and/or the moisture of a strand-shaped, continuous fiber batch, and textile machine |
06/17/2009 | EP2069542A2 Methodology for detection, enumeration, propagation and manipulation of bacteriophages |
06/17/2009 | EP2069538A1 Compositions and methods for therapy and diagnosis of cancer and cancer metastasis |
06/17/2009 | EP2069524A2 Compositions and multiplex assays for measuring biological mediators of physiological health |
06/17/2009 | EP2069499A2 Endophyte enhanced seedlings with increased pest tolerance |
06/17/2009 | EP2069460A2 Fluorescent cell markers |
06/17/2009 | EP2069400A1 Methods of treating rsv infections and related conditions |
06/17/2009 | EP2069395A1 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
06/17/2009 | EP2069394A1 Identification of candidate vaccine antigens from dichelobacter nodosus |
06/17/2009 | EP2069390A2 Opsin stabilizing compounds and methods of use |
06/17/2009 | EP2069385A1 Membranous protein immobilisation on a carrier using an amphiphile molecule |
06/17/2009 | EP2069384A2 Biomarker fragments for the detection of human bnp |
06/17/2009 | EP2069358A2 Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label |
06/17/2009 | EP2068954A1 Molecular assembly on a substrate |
06/17/2009 | EP2068939A2 Methods of screening agents for activity using teleosts |
06/17/2009 | EP2068929A2 Method for detecting and treating skin disorders |
06/17/2009 | EP2068926A2 Il-9 in fibrotic and inflammatory disease |
06/17/2009 | EP2068924A2 Interferon alpha-induced pharmacodynamic markers |
06/17/2009 | EP2068920A2 Ccr2 antagonists for treatment of fibrosis |
06/17/2009 | EP2068849A2 Kinase inhibitors, and methods of using and identifying kinase inhibitors |
06/17/2009 | EP2068698A2 Self-contained test unit for testing body fluids |
06/17/2009 | EP1962668B1 Sandwich sensor for the determination of an analyte concentration |
06/17/2009 | EP1938102A4 Improved target ligand detection |
06/17/2009 | EP1928614A4 Method for diagnosing infections |
06/17/2009 | EP1851526A4 Trace gas sensor with reduced degradation |
06/17/2009 | EP1780215B1 Crohn's disease antibody epitope peptide and reagent for testing crohn's disease |
06/17/2009 | EP1719051A4 Biological dataset profiling of asthma and atopy |
06/17/2009 | EP1714160A4 Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants |
06/17/2009 | EP1713900A4 Methods and systems for annotating biomolecular sequences |
06/17/2009 | EP1711801B1 Surface inspection using a non-vibrating contact potential probe |